论文部分内容阅读
目的:探讨住院患者和社区内患者泌尿系统内大肠埃希菌耐药性的分布情况。方法:以2014年9月至2016年9月为期,分别在住院和社区门诊部挑选患者尿液样本各127份,对尿液中的大肠埃希菌进行分离提纯,并通过微生物培养和药敏测试确定其耐药性分布情况,其中住院部患者数据记A组;社区门诊部数据记B组。结果:A组菌株对庆大霉素耐药率为68.50%(87/127),明显高于B组54.33%(69/127),同时A组菌株对哌拉西林、头孢他啶等药物的耐药性均明显高于B组,两组数据具有统计学意义(P<0.05)。结论:住院患者泌尿系统感染的大肠埃希菌耐药性明显较高,需要在临床治疗时重点注意。
Objective: To investigate the distribution of Escherichia coli resistance in the urinary system of patients in hospital and community. Methods: From September 2014 to September 2016, 127 urine samples were collected from inpatients and community outpatient clinics to separate and purify Escherichia coli in urine. The microorganism culture and drug sensitivity Test to determine the distribution of drug resistance, including patient data in hospital A group; community outpatient data B group. Results: The drug resistance rate of gentamicin in group A was 68.50% (87/127), significantly higher than that in group B (54.33%, 69/127), while the drug resistance of group A to piperacillin and ceftazidime Both were significantly higher than those in group B. The data of two groups were statistically significant (P <0.05). Conclusion: In hospital patients with urinary tract infection of Escherichia coli was significantly higher drug resistance, the need to focus on clinical treatment.